The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
Program Overview
Indonesia Ministry of Health (MoH) has recently accelerated the nationwide introduction of several new vaccines in 2022 and 2023, namely Pneumococcal Conjugated Vaccine (PCV), Rotavirus (RV) vaccine, and Human Papilloma Virus (HPV) vaccine. PCV was scaled up from 2 demonstration sites in 2016 to 4 provinces in 2021 and to nationwide in September 2022. The RV vaccine was firstly introduced in 2022 to 21 districts in 18 provinces and proven to be fit into routine immunization schedule and well received by community, so it being nationally scaled up in August 2023. The MoH also committed to scale up HPV from concentrated targeted districts to nationwide scale up by August 2023.
CHAI had been supporting the MOH in introducing and accelerating the new vaccine’s introduction (NVI) since 2027 and continue to support and strengthen its implementation. To continue CHAI strong support to EPI, CHAI is looking for NVI Program Officers (POs) that will support EPI in the early NVI implementation (rapid monitoring, logistic review, coverage analysis, etc.) and continuous technical assistance at national and sub-national levels. The POs will report to Senior Program Officer NVI and work under guidance of CHAI Indonesia Senior Program Officer NVI and Senior Program Manager, and in coordination with Senior Program Officer MSC to deliver intended activities.
#jobreference1 #region2
Level of Education: Bachelor Degree
Work Hours: 8
Experience in Months: No requirements